| Literature DB >> 24748009 |
Chuanlong Wu1, Xinhua Qu1, Fengxiang Liu1, Huiwu Li1, Yuanqing Mao1, Zhenan Zhu1.
Abstract
PURPOSE: The purpose of this hospital-based case-control study was to evaluate the risk factors for periprosthetic joint infection (PJI) of total hip arthroplasty (THA) and total knee arthroplasty (TKA) in Chinese patients.Entities:
Mesh:
Year: 2014 PMID: 24748009 PMCID: PMC3991645 DOI: 10.1371/journal.pone.0095300
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Patient demographics and other characteristics according to occurrence of PJI.
| Periprosthetic joint infection | |||
| Yes (n = 45) | No (n = 252) | P | |
|
| 0.107 | ||
| <45 | 2 (4.4) | 19 (7.5) | |
| 45–65 | 13 (28.9) | 113 (44.8) | |
| 65–75 | 19 (42.2) | 68 (27.0) | |
| ≥75 | 11 (24.4) | 52 (20.6) | |
|
| 0.843 | ||
| Male | 20 (44.4) | 108 (42.9) | |
| Female | 25 (55.6) | 144 (57.1) | |
|
| 0.058 | ||
| Rural | 18 (40.0) | 66 (26.2) | |
| Urban | 27 (60.0) | 186 (73.8) | |
|
| 0.492 | ||
| THA | 28 (62.2) | 170 (67.5) | |
| TKA | 17 (37.8) | 82 (32.5) | |
|
| 0.237 | ||
| Osteoarthritis | 8 (17.8) | 54 (21.4) | |
| Femoral head necrosis | 8 (17.8) | 30 (11.9) | |
| Developmental dysplasia of the hip | 6 (13.3) | 40 (15.9) | |
| Fracture | 11(24.4) | 88 (34.9) | |
| Rheumatoid arthritis | 10 (22.2) | 27 (10.7) | |
| Other | 2 (4.4) | 13 (5.2) | |
All values are expressed as n (%).
*According to chi-square test.
Abbreviations: THA, total hip arthroplasty; TKA, total knee arthroplasty.
Patient comorbidities according to occurrence of PJI.
| Periprosthetic joint infection | |||
| Yes | No | P | |
|
|
| ||
|
| 1 (2.2) | 5 (2.0) | |
|
| 18 (40.0) | 156 (61.9) | |
|
| 26 (57.8) | 91 (36.1) | |
|
| 17 (37.8) | 24 (9.5) |
|
|
| 8 (17.8) | 6 (2.4) |
|
|
| 15 (33.3) | 34 (13.5) |
|
| Anemia | 3 (6.7) | 31 (12.3) | 0.274 |
| Dental procedure with antibiotic | 5 (11.1) | 18(7.1) | 0.359 |
| Neurologic disease | 1 (2.2) | 13 (5.2) | 0.392 |
| Oncologic disease | 1 (2.2) | 12 (4.8) | 0.443 |
| Dental procedure | 8 (26.7) | 35 (13.9) | 0.495 |
| Ankylosing spondylitis | 1 (2.2) | 11 (4.4) | 0.501 |
| Tobacco use | 5 (11.1) | 37 (14.7) | 0.527 |
| Hypertension | 9 (20.0) | 60 (23.8) | 0.577 |
| Cardiovascular event | 5 (11.1) | 31 (12.3) | 0.822 |
| Chronic pulmonary disease | 7 (15.6) | 36 (14.3) | 0.824 |
| Chronic liver disease | 4 (8.9) | 20 (7.9) | 0.829 |
| Prostatic disorder | 4 (8.9) | 25 (9.9) | 0.830 |
| Cerebral infarction | 3 (6.7) | 15 (6.0) | 0.853 |
| Substance abuse | 4 (8.9) | 24 (9.5) | 0.893 |
| Renal disease | 6 (13.3) | 32 (12.7) | 0.907 |
| Gout | 3 (6.7) | 16 (6.3) | 0.936 |
| History of tuberculosis | 2 (4.4) | 11 (4.4) | 0.981 |
All values are expressed as n (%).
*According to the chi-square test.
Independent risk factors for PJI after multivariate regression analysis.
| Patient demographics/comorbid conditions | Odds ratio | 95% CI | P |
|
| 5.47 | 1.77–16.97 |
|
|
| 3.36 | 1.30–8.69 |
|
|
| 2.77 | 1.20–6.40 |
|
|
| 2.63 | 1.13–6.10 |
|
|
| 2.95 | 1.06–8.23 |
|
| Age (>75 y vs. 45–65 y) | 2.54 | 0.83–7.79 | 0.103 |
| Treatment of diabetes (insulin) | 3.69 | 0.63–21.69 | 0.148 |
| Chronic pulmonary disease | 2.35 | 0.68–8.15 | 0.177 |
| Hypertension | 0.55 | 0.19–1.61 | 0.279 |
| Substance abuse | 1.80 | 0.45–7.21 | 0.408 |
| Cerebral infarction | 0.46 | 0.07–3.12 | 0.426 |
| Dental procedure | 1.71 | 0.38–7.70 | 0.487 |
| Renal disease | 1.43 | 0.43–4.80 | 0.559 |
| Gout | 1.51 | 0.32–7.10 | 0.600 |
| Cardiovascular event | 1.32 | 0.39–4.52 | 0.654 |
| Chronic liver disease | 1.34 | 0.36–5.04 | 0.663 |
| Anemia | 0.74 | 0.17–3.26 | 0.688 |
| Tobacco use | 1.29 | 0.35–4.76 | 0.703 |
| Ankylosing spondylitis | 0.62 | 0.05–7.43 | 0.704 |
| BMI (<18.5 kg/m2 vs. 18.5–28 kg/m2) | 1.55 | 0.12–20.16 | 0.740 |
| Dental procedure with antibiotic | 1.38 | 0.20–9.54 | 0.743 |
| THA (vs. TKA) | 0.89 | 0.37–2.12 | 0.789 |
| Male (vs. female) | 0.95 | 0.40–2.21 | 0.899 |
| Age (<45 y vs. 45–65 y) | 0.91 | 0.15–5.40 | 0.919 |
| Prostatic disorder | 0.94 | 0.23–3.87 | 0.930 |
| Oncologic disease | 0.90 | 0.08–10.69 | 0.936 |
| Neurologic disease | 0.94 | 0.10–8.95 | 0.958 |
| History of tuberculosis | 1.02 | 0.16–6.44 | 0.980 |
|
| |||
| Rheumatoid arthritis (vs. osteoarthritis) | 2.81 | 0.69–11.47 | 0.151 |
| Femoral head necrosis | 2.02 | 0.52–7.89 | 0.314 |
| Developmental dysplasia of the hip | 1.54 | 0.40–5.89 | 0.527 |
| Other | 1.72 | 0.19–15.13 | 0.626 |
| Fracture | 0.83 | 0.24–2.89 | 0.772 |
Abbreviations: BMI, body mass index; CI, confidence interval; THA, total hip arthroplasty; TKA, total knee arthroplasty.
Data from previous studies examining risk factors for periprosthetic joint infection (PJI) or surgical site infection (SSI) in patients who underwent THA and TKA.
| Author | Year | Country | Research type | Total number of patients | Position | Statistical method |
| Bozic et al. | 2013 | USA | Case–control | 587 | THA-PJI | Multivariate Cox regression |
| Namba et al. | 2013 | USA | Cohort study | 56,216 | TKA-SSI | Multivariate Cox regression |
| Everhart at al. | 2013 | USA | Cohort study | 1,891 | TJA-SSI | Logistic regression |
| Poultsides et al. | 2012 | USA | Cohort study | 1,196,691 | Hip and knee arthroplasty-PJI | Logistic regression |
| Namba et al. | 2012 | USA | Cohort study | 30,491 | THA-SSI | Multivariate Cox regression |
| Dale et al. | 2012 | Norway | Cohort study | 432,168 | THA-PJI | Multivariate Cox regression |
| Bozic et al. | 2012 | USA | Cohort study | 40,919 | THA-PJI | Multivariate Cox regression |
| Bozic et al. | 2012 | USA | Cohort study | 83,011 | TKA-PJI | Multivariate Cox regression |
| Song et al. | 2012 | Republic of Korea | Cohort study | 6,848 | THA,TKA-SSI | Logistic regression |
| Peel et al. | 2011 | Australia | Case–control | 189 | Hip and knee arthroplasty-PJI | Logistic regression |
| Pulido et al. | 2008 | USA | Cohort study | 9,245 | Hip and knee arthroplasty-PJI | Logistic regression |
| Babkin et al. | 2007 | Israel | Case-control | 180 | TKA-SSI | Logistic regression |
| Kasteren et al. | 2007 | Holland | Cohort study | 1,922 | THA-SSI | Logistic regression |
| Lai et al. | 2007 | Canada | Case-control | 52 | Hip and knee arthroplasty-PJI | Logistic regression |
| Ridgeway et al. | 2005 | UK | Cohort study | 24,808 | Hip arthroplasty-SSI | Logistic regression |
Abbreviations: THA, total hip arthroplasty; TKA, total knee arthroplasty; TJA, total joint arthroplasty.
Data from previous studies examining risk factors (positive results in this article) for periprosthetic joint infection or surgical site infection in patients who underwent THA and TKA, in detail.
| Literatures | Patient demographics/comorbid conditions | Age, y | BMI, kg/m2 | Diabetes | Alcohol abuse |
|
|
|
|
| 1.11 (0.53–2.30), 0.79 | |
|
|
|
|
| 1.28 (1.03–1.60), 0.03 | |
|
|
|
| 1.83 (1.02–3.27), 0.05 | ||
|
|
|
|
|
| 1.57 (1.23–2.00), 0.01 |
|
|
|
|
| 1.25 (0.85–1.83), 0.26 | |
|
|
|
| |||
|
|
|
| 1.31 (1.12–1.53), 0.06 | 1.72 (0.98–3.01), 0.06 | |
|
|
|
| 1.19 (1.06–1.34), 0.01 | 1.11 (0.63–1.97), 0.71 | |
|
|
|
| |||
|
|
|
| |||
|
|
|
| |||
|
|
|
| |||
|
|
|
| 3.91 (1.06–14.44), 0.04 | ||
|
|
|
|
Abbreviations: BMI, body mass index; HR, hazard ratio; NS, not significant; OA, osteoarthritis; OR, odds ratio; THA, total hip arthroplasty; TKA, total knee arthroplasty; RR, relative risk.